KALA BIO, Inc. — Director's Dealing 2025

Dec 2, 2025

SEC Form 3/A — Form 3/A

Issuer: KALA BIO, Inc. (KALA)
CIK: 0001479419
Period of Report: 2025-11-23

Reporting Person: Lazar David E. (Director, Chief Executive Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Convertible Loan	$1.017		Common Stock (368614)		Direct

Footnotes

F1: No shares of common stock are beneficially owned.

F2: Not Applicable

F3: On November 9, 2025, the Reporting Person, as "Lender", entered into a Convertible Loan Agreement (the "Agreement") with Issuer pursuant to which Lender agreed to loan the Issuer up to an amount of $375,000. Pursuant to the Agreement, the Lender had the right in its discretion at any time prior to the full repayment of the Loan Amount (as defined in the Agreement) to the Lender, to convert all or any of the then outstanding and unpaid portion of the Loan Amount into Issuer's common stock at the "Conversion Price" (as defined in the Agreement). In accordance with the provisions of the Agreement, as of the Date of Event Requiring Statement, the conversion rate is $1.017 per share of Common Stock.